Literature DB >> 17714681

Among pregnant women with bacterial vaginosis, the hydrolytic enzymes sialidase and prolidase are positively associated with interleukin-1beta.

Sabina Cauci1, Jennifer Flatow Culhane, Manuela Di Santolo, Kelly McCollum.   

Abstract

OBJECTIVE: The objective of the study was to explore the mechanisms of local innate immunity induction and modulation in pregnant women with bacterial vaginosis (BV). STUDY
DESIGN: A total of 200 singleton pregnant women in early gestation (12 +/- 4 weeks) with BV (Nugent 7-10) without concurrent vaginal infections with Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, syphilis, and yeast. Concentrations of vaginal interleukin (IL)-1beta and IL-8, the number of neutrophils, and the levels of sialidase and prolidase hydrolytic enzymes were determined in vaginal fluid.
RESULTS: Concentrations of vaginal IL-1beta had a strong positive correlation with levels of sialidase (P < .001) and prolidase (P < .001). Conversely, such enzymes were negatively correlated with the ratio of IL-8/IL-1beta (both P < .001) and were not significantly associated with concentrations of IL-8. Notably, the number of vaginal neutrophils had a negative correlation with sialidase (P = .007).
CONCLUSION: The strong induction of IL-1beta in BV-positive women appears to be associated with the production of the hydrolytic enzymes sialidase and prolidase by BV-associated bacteria. However, these 2 enzymes may inhibit the expected amplification of the proinflammatory IL-1beta cascade as evaluated by the down-regulation of the IL-8/IL-1beta ratio. A blunted response to IL-1beta signals may cause the poor rise of neutrophils, which is peculiar to BV. This impairment of local defense may contribute to increased susceptibility to adverse outcomes in BV-positive pregnant women.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17714681     DOI: 10.1016/j.ajog.2007.05.035

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  31 in total

1.  Severity of bacterial vaginosis and the risk of sexually transmitted infection.

Authors:  Jenifer E Allsworth; Jeffrey F Peipert
Journal:  Am J Obstet Gynecol       Date:  2011-02-27       Impact factor: 8.661

Review 2.  The role of bacterial vaginosis and trichomonas in HIV transmission across the female genital tract.

Authors:  Paria Mirmonsef; Laurie Krass; Alan Landay; Gregory T Spear
Journal:  Curr HIV Res       Date:  2012-04       Impact factor: 1.581

3.  Gardnerella vaginalis and Prevotella bivia Trigger Distinct and Overlapping Phenotypes in a Mouse Model of Bacterial Vaginosis.

Authors:  Nicole M Gilbert; Warren G Lewis; Guocai Li; Dorothy K Sojka; Jean Bernard Lubin; Amanda L Lewis
Journal:  J Infect Dis       Date:  2019-08-30       Impact factor: 5.226

Review 4.  Vaginal microbiota and susceptibility to HIV.

Authors:  McKenna C Eastment; R Scott McClelland
Journal:  AIDS       Date:  2018-03-27       Impact factor: 4.177

5.  Higher Levels of a Cytotoxic Protein, Vaginolysin, in Lactobacillus-Deficient Community State Types at the Vaginal Mucosa.

Authors:  Rebecca G Nowak; Tara M Randis; Purnahamsi Desai; Xin He; Courtney K Robinson; Jessica M Rath; Elbert D Glover; Adam J Ratner; Jacques Ravel; Rebecca M Brotman
Journal:  Sex Transm Dis       Date:  2018-04       Impact factor: 2.830

Review 6.  Obstetric and gynecological diseases and complications resulting from vaginal dysbacteriosis.

Authors:  Stefan Miladinov Kovachev
Journal:  Microb Ecol       Date:  2014-04-08       Impact factor: 4.552

Review 7.  The Human Microbiome during Bacterial Vaginosis.

Authors:  Andrew B Onderdonk; Mary L Delaney; Raina N Fichorova
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

8.  Bacterial Vaginosis and Subclinical Markers of Genital Tract Inflammation and Mucosal Immunity.

Authors:  Andrea Ries Thurman; Thomas Kimble; Betsy Herold; Pedro M M Mesquita; Raina N Fichorova; Hassan Y Dawood; Titilayo Fashemi; Neelima Chandra; Lorna Rabe; Tina D Cunningham; Sharon Anderson; Jill Schwartz; Gustavo Doncel
Journal:  AIDS Res Hum Retroviruses       Date:  2015-07-23       Impact factor: 2.205

9.  Functional and phylogenetic characterization of Vaginolysin, the human-specific cytolysin from Gardnerella vaginalis.

Authors:  Shari E Gelber; Jorge L Aguilar; Kanako L T Lewis; Adam J Ratner
Journal:  J Bacteriol       Date:  2008-04-04       Impact factor: 3.490

Review 10.  Nanoparticle-based drug delivery to the vagina: a review.

Authors:  Laura M Ensign; Richard Cone; Justin Hanes
Journal:  J Control Release       Date:  2014-05-14       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.